天弘国证生物医药ETF发起式联接A(011040)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
1,080,363.01 |
621,236.64 |
53,017.10 |
310,747.24 |
| 存出保证金 |
299,173.50 |
247,889.99 |
233,347.88 |
268,302.82 |
| 交易性金融资产 |
1,192,877,320.32 |
1,030,243,797.39 |
1,005,740,019.44 |
1,052,088,540.18 |
| 其中：股票投资 |
17,417,320.32 |
6,809,032.73 |
13,841,277.54 |
27,369,868.02 |
| 债券投资 |
- |
- |
1,004,407.40 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
22,434,110.24 |
- |
653,853.28 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
19,636,807.12 |
13,330,608.68 |
3,070,461.79 |
7,348,555.90 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,302,720,351.42 |
1,105,880,628.15 |
1,066,507,833.08 |
1,123,045,583.19 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
4,033,114.79 |
1,878,023.31 |
- |
| 应付赎回款 |
46,020,857.42 |
10,784,393.90 |
6,653,209.31 |
12,266,433.18 |
| 应付管理人报酬 |
29,786.46 |
26,359.67 |
28,242.01 |
33,653.79 |
| 应付托管费 |
5,957.28 |
5,271.95 |
5,648.41 |
6,730.74 |
| 应付销售服务费 |
151,604.72 |
149,477.12 |
139,716.42 |
166,089.55 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
114,762.89 |
200,554.84 |
114,193.27 |
216,736.51 |
| 负债合计 |
46,322,968.77 |
15,199,172.27 |
8,819,032.73 |
12,689,643.77 |
| 所有者权益 |
| 实收基金 |
3,215,138,940.65 |
2,614,783,886.70 |
2,631,594,008.27 |
2,818,907,869.65 |
| 未分配利润 |
-1,958,741,558.00 |
-1,524,102,430.82 |
-1,573,905,207.92 |
-1,708,551,930.23 |
| 所有者权益合计 |
1,256,397,382.65 |
1,090,681,455.88 |
1,057,688,800.35 |
1,110,355,939.42 |
| 负债及所有者权益总计 |
1,302,720,351.42 |
1,105,880,628.15 |
1,066,507,833.08 |
1,123,045,583.19 |
微信公众号
证券之星APP
基本资料
